16 Dunedin Income Growth Investment Trust PLC
On the rarer occasions where our assessment of a
company’s quality or prospects changes in a meaningful
way, we act accordingly. In the first half of the year, we
exited two holdings where our conviction had reduced -
the long-standing holding Novo-Nordisk and the more
recent addition Azelis, reinforcing the discipline at the
heart of our process. In both cases, the shares weakened
significantly after exit. Edenred’s share price fell over the
year, primarily due to regulatory changes in Italy and
Brazil that have increased uncertainty around fee
economics and profitability. Following detailed analysis,
including attending the company’s Capital Markets Day in
Paris, we have added to the holding because we believe
the current valuation offers the potential for attractive
total returns as the regulatory and sentiment backdrop
becomes clearer. We continually re-examine our
assumptions on total return potential and ensure valuation
compensates for the risks being taken, reallocating capital
to higher conviction opportunities when that balance no
longer holds.
Portfolio Activity
Investment activity reflected our continued focus on
delivering long‑term returns while maintaining a balanced
portfolio, with new positions funded by trimming or exiting
holdings that offered less compelling prospective returns.
With regards to the impact of AI, we backed our existing
positions by adding to RELX, Sage, and Softcat, where we
believe share price weakness does not reflect strong
underlying fundamentals or the resilience provided by
proprietary data, customer relationships and embedded
roles in mission critical workflows
In the Consumer Staples sector, we added to Haleon.
While its shares weakened on slower North American
growth, we believe its leading consumer health brands
and strengthening balance sheet support attractive
earnings and dividend growth relative to peers. In addition,
we introduced Tesco, where we see an attractive
combination of resilience and self‑help. The business
benefits from a strong position in UK food retail, and we
see scope for further progress through multi‑channel
execution and the continued development of
complementary profit streams. We funded this
purchase by exiting Unilever, where we judged
prospective returns to be less attractive than the
opportunities available elsewhere.
We introduced two long‑standing watchlist holdings,
Experian and Compass. Experian provides data and
analytics to businesses and consumers and, after several
years of investment in product expansion and an
integrated platform, we believe it is positioned for stronger
growth, improving cash generation and rising returns.
Compass is a global catering leader, taking share in a
large addressable market with scope to apply US best
practice to improve profitability in Europe. Both
companies offer a below market starting yield but the
potential for strong dividend growth which, alongside
balance sheet optionality, supports attractive
prospective returns.
We also added LondonMetric, a specialist real estate
company with a diversified portfolio across logistics,
convenience retail, healthcare and leisure assets, which
supports an attractive income profile and the potential for
modest growth. This was funded by exiting Primary Health
Properties following its successful acquisition of Assura,
and recycling capital into a holding we viewed as the
stronger long-term income opportunity, supported by a
high-quality portfolio, a strong management team and a
robust balance sheet.
Consistent with our view that the opportunity set for mid-
caps is improving, we introduced three new holdings.
Baltic Classifieds is a market‑leading digital classifieds
platform in the Baltics with strong cash generation and
attractive long‑term growth characteristics. XPS Pensions
is a pensions advisory and administration business with a
strong growth record, high revenue visibility supported by
regulatory tailwinds, and robust cash generation that
underpins an attractive and growing dividend. Kainos is a
digital transformation specialist serving public sector,
healthcare and commercial clients, and we see improving
momentum alongside longer‑term opportunities from its
product pipeline.
In the Financials sector, we introduced
Standard
Chartered as we believe the market has yet to fully reflect
the improvement in its returns profile and the growth
potential in its wealth business, supported by its broad
geographic footprint. We also participated in the rights
issue for Chesnara to finance the acquisition of HSBC Life
(UK) and subsequently reduced the position meaningfully
to manage risk as the transaction completed. We added
to NatWest in the volatility that followed ‘Liberation Day’,
and the shares subsequently recovered.
Investment Mana
er’s Review
Continued